2008年至2021年间日本医生与制药行业关系的变化:一项全国调查
Sayaka Saito1, Kei Mukohara2, Kazuhiro Shimomura3,4
1Department of General Medicine, National Hospital Organization Kasumigaura Medical Center, Tsuchiura, Ibaraki, Japan.
日本医生仍然经常与制药业代表 (PRs) 互动,尽管自2008年以来,参与度有所下降. 限制与公关人员会面的规则似乎有效地减少了医生的参与,并促进了对礼物的批判性看法.
科学领域:
- 医学营销与伦理学
- 制药行业关系 制药行业关系
- 医生参与策略 医生参与策略
背景情况:
- 2008年的一项调查显示,在日本,医生经常互动,并对制药业代表 (PR) 持积极态度.
- 2019年更新的行业代码限制了促销援助,而COVID-19大流行也限制了面对面的会议.
- 这项研究旨在评估当前医生与PR的参与以及对他们的态度,比较2008年至2021年的数据.
研究的目的:
- 评估日本医生目前参与制药推广活动的程度.
- 评估医生对与制药公司代表 (PRs) 的关系的态度.
- 确定2008年至2021年间医生与公关互动和态度的变化以及影响对礼物的积极态度的因素.
主要方法:
- 2021年,在七个专业的1636名医生中进行了全国邮件调查.
- 响应率为63.2%.
- 收集的数据包括面对面的会议频率,接收餐点,对公关人员角色的看法,以及对礼物和处方行为的看法.
主要成果:
- 大多数医生 (78.8%) 与公关人员会面,但很少有人吃饭 (4.5%).
- 公关人员因其在继续医学教育 (66.1%) 和提供药物信息 (74.2%) 方面的作用而得到认可.
- 医生对礼物的态度分歧,大多数人认为文具和餐饮不会影响处方.
结论:
- 在日本,医生参与制药推广活动仍然很常见,尽管有所下降.
- 禁止与公关人员会面的规定似乎有效地限制了医生的参与,并培养了对礼物的批评态度.
- 诸如医生的性别,专业,互动频率和感知信息价值等因素影响了对礼物的态度.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
05:59An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules
Published on: November 4, 2022
相关概念视频
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
